CHRU de Lille - Hôpital Huriet

Lille, NORD 59037

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Metastatic or Unresectable Cutaneous Melanoma

Studies at this site

• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed